Europe Schizophrenia Market and Competitive Landscape - 2017

  • ID: 4377599
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Schizophrenia Market and Competitive Landscape - 2017, provides comprehensive insights into Schizophrenia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Schizophrenia market size and drug sales. This research also provides insights into Schizophrenia epidemiology and late stage pipeline.

The report is classified into nine sections - Schizophrenia overview with definitions, symptoms, etiology, diagnosis, treatment options; Schizophrenia pipeline insights covering late stage clinical trials pipeline; Schizophrenia prevalence trends by countries; Schizophrenia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Schizophrenia pipeline: Find out the drugs in clinical trials for Schizophrenia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Schizophrenia epidemiology: Find out the prevalence of Schizophrenia by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Schizophrenia products: Identify key products marketed and prescribed for Schizophrenia by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Schizophrenia market size: Find out the market size for Schizophrenia drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Schizophrenia drug sales: Find out the sales of Schizophrenia drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Schizophrenia drugs sales forecast: Sales forecast for Schizophrenia drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Schizophrenia market share analysis: Find out the market shares of Schizophrenia drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Schizophrenia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Schizophrenia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Schizophrenia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Schizophrenia: Disease Overview
1.1. Schizophrenia Symptoms
1.2. Schizophrenia Etiology
1.3. Schizophrenia Diagnosis
1.4. Schizophrenia Treatment Options

2. Schizophrenia Pipeline Insights
2.1. Schizophrenia Phase 3 Clinical Trials
2.2. Schizophrenia Phase 2 Clinical Trials
2.3. Schizophrenia Phase 1 Clinical Trials

3. Schizophrenia Epidemiology Analysis

4. Germany Schizophrenia Market Insights
4.1. Marketed Products for Schizophrenia in Germany
4.2. Germany Schizophrenia Market Size & Forecast
4.3. Germany Schizophrenia Product Sales Forecast
4.4. Germany Schizophrenia Market Share Analysis

5. France Schizophrenia Market Insights
5.1. Marketed Products for Schizophrenia in France
5.2. France Schizophrenia Market Size & Forecast
5.3. France Schizophrenia Product Sales Forecast
5.4. France Schizophrenia Market Share Analysis

6. Italy Schizophrenia Market Insights
6.1. Marketed Products for Schizophrenia in Italy
6.2. Italy Schizophrenia Market Size & Forecast
6.3. Italy Schizophrenia Product Sales Forecast
6.4. Italy Schizophrenia Market Share Analysis

7. Spain Schizophrenia Market Insights
7.1. Marketed Products for Schizophrenia in Spain
7.2. Spain Schizophrenia Market Size & Forecast
7.3. Spain Schizophrenia Product Sales Forecast
7.4. Spain Schizophrenia Market Share Analysis

8. UK Schizophrenia Market Insights
8.1. Marketed Products for Schizophrenia in UK
8.2. UK Schizophrenia Market Size & Forecast
8.3. UK Schizophrenia Product Sales Forecast
8.4. UK Schizophrenia Market Share Analysis

9. Europe Schizophrenia Market Insights
9.1. Europe Schizophrenia Market Size & Forecast
9.2. Europe Schizophrenia Product Sales Forecast
9.3. Europe Schizophrenia Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Schizophrenia Phase 3 Clinical Trials, Global, 2017
Table 2: Schizophrenia Phase 2 Clinical Trials, Global, 2017
Table 3: Schizophrenia Phase 1 Clinical Trials, Global, 2017
Table 4: Schizophrenia Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Schizophrenia in Germany, 2017
Table 6: Germany Schizophrenia Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Schizophrenia Product Sales ($mn), 2012 - 2021
Table 8: Germany Schizophrenia Market Trends, 2012 - 2021
Table 9: Marketed Products for Schizophrenia in France, 2017
Table 10: France Schizophrenia Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Schizophrenia Product Sales ($mn), 2012 - 2021
Table 12: France Schizophrenia Market Trends, 2012 - 2021
Table 13: Marketed Products for Schizophrenia in Italy, 2017
Table 14: Italy Schizophrenia Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Schizophrenia Product Sales ($mn), 2012 - 2021
Table 16: Italy Schizophrenia Market Trends, 2012 - 2021
Table 17: Marketed Products for Schizophrenia in Spain, 2017
Table 18: Spain Schizophrenia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Schizophrenia Product Sales ($mn), 2012 - 2021
Table 20: Spain Schizophrenia Market Trends, 2012 - 2021
Table 21: Marketed Products for Schizophrenia in UK, 2017
Table 22: UK Schizophrenia Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Schizophrenia Product Sales ($mn), 2012 - 2021
Table 24: UK Schizophrenia Market Trends, 2012 - 2021
Table 25: Europe Schizophrenia Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Schizophrenia Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Schizophrenia Pipeline by Phase (%), Global, 2017
Figure 2: Schizophrenia Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Schizophrenia Market Size ($mn), 2012 - 2021
Figure 4: Germany Schizophrenia Product Sales ($mn), 2012 - 2021
Figure 5: Germany Schizophrenia Market Share by Products (%), 2016
Figure 6: Germany Schizophrenia Market - Future Market Share (%), 2021
Figure 7: France Schizophrenia Market Size ($mn), 2012 - 2021
Figure 8: France Schizophrenia Product Sales ($mn), 2012 - 2021
Figure 9: France Schizophrenia Market Share by Products (%), 2016
Figure 10: France Schizophrenia Market - Future Market Share (%), 2021
Figure 11: Italy Schizophrenia Market Size ($mn), 2012 - 2021
Figure 12: Italy Schizophrenia Product Sales ($mn), 2012 - 2021
Figure 13: Italy Schizophrenia Market Share by Products (%), 2016
Figure 14: Italy Schizophrenia Market - Future Market Share (%), 2021
Figure 15: Spain Schizophrenia Market Size ($mn), 2012 - 2021
Figure 16: Spain Schizophrenia Product Sales ($mn), 2012 - 2021
Figure 17: Spain Schizophrenia Market Share by Products (%), 2016
Figure 18: Spain Schizophrenia Market - Future Market Share (%), 2021
Figure 19: UK Schizophrenia Market Size ($mn), 2012 - 2021
Figure 20: UK Schizophrenia Product Sales ($mn), 2012 - 2021
Figure 21: UK Schizophrenia Market Share by Products (%), 2016
Figure 22: UK Schizophrenia Market - Future Market Share (%), 2021
Figure 23: Europe Schizophrenia Market Size ($mn), 2012 - 2021
Figure 24: Europe Schizophrenia Product Sales ($mn), 2012 - 2021
Figure 25: Europe Schizophrenia Market Share by Products (%), 2016
Figure 26: Europe Schizophrenia Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll